Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý
Also in the Knowledge Center
/ Jan 01, 1989
Rhodium hydrogenation catalysts particularly for stereoselective hydrogenation of methacycline to doxycycline
Read more
Scientific Article
/ Jan 01, 1989
Homogeneous catalytic system for hydrogenation of methylenetetracyclines and a process for the preparation of same
Read more
Scientific Article
Scientific Article